Skip to content

09995.HK

RemeGen Co., Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 64.85
+2.37%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
6.62x
P/E 2027E
38.92x
P/E 2028E
20.42x
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
5.32x
PEG TTM
—
Price / book
3.71x
Price / sales
3.88x
Price / cash flow
6.85x

Enterprise value

Enterprise value
HKD 30.6B
EV / sales
3.27x
EV / EBITDA
5.02x
EV / EBIT
5.35x
Market cap
HKD 36.3B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026